Dr. Roger Kobayashi, M.D

NPI: 1093707754
Total Payments
$90,088
2024 Payments
$1,004
Companies
29
Transactions
296
Medicare Patients
664
Medicare Billing
$94,905

Payment Breakdown by Category

Travel$31,054 (34.5%)
Other$30,526 (33.9%)
Research$10,100 (11.2%)
Consulting$8,898 (9.9%)
Food & Beverage$8,047 (8.9%)
Education$1,463 (1.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $31,054 49 34.5%
Honoraria $28,850 9 32.0%
Unspecified $10,100 5 11.2%
Consulting Fee $8,898 6 9.9%
Food and Beverage $8,047 210 8.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,676 2 1.9%
Education $1,463 15 1.6%

Payments by Type

General
$79,988
291 transactions
Research
$10,100
5 transactions

Top Paying Companies

Company Total Records Latest Year
Octapharma USA, Inc. $62,541 115 $0 (2023)
Shire North American Group Inc $20,604 43 $0 (2019)
PFIZER INC. $2,653 12 $0 (2024)
CSL Behring $1,443 32 $0 (2023)
GlaxoSmithKline, LLC. $351.96 19 $0 (2021)
Grifols USA, LLC $333.52 8 $0 (2024)
Horizon Therapeutics plc $326.01 11 $0 (2023)
Grifols Shared Services North America, Inc. $281.12 4 $0 (2023)
Genentech, Inc. $249.75 3 $0 (2020)
AstraZeneca Pharmaceuticals LP $175.30 4 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,004 3 PFIZER INC. ($740.00)
2023 $5,025 24 Octapharma USA, Inc. ($4,627)
2022 $20,594 16 Octapharma USA, Inc. ($20,279)
2021 $9,481 40 Octapharma USA, Inc. ($7,361)
2020 $1,667 27 Octapharma USA, Inc. ($1,088)
2019 $11,949 60 Octapharma USA, Inc. ($10,911)
2018 $32,010 84 Octapharma USA, Inc. ($17,944)
2017 $8,357 42 Shire North American Group Inc ($7,299)

All Payment Transactions

296 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
07/10/2024 Grifols USA, LLC Xembify (Biological) Food and Beverage In-kind items and services $149.88 General
Category: Immunology and Neurology
02/25/2024 Pharming Healthcare, Inc. JOENJA (Drug) Food and Beverage In-kind items and services $114.33 General
Category: APDS
01/30/2024 PFIZER INC. PAXLOVID (Drug) Consulting Fee Cash or cash equivalent $740.00 General
Category: INFECTIOUS DISEASES
11/01/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Cash or cash equivalent $1,300.00 Research
Study: SCGAM-06 • Category: IMMUNOLOGY
10/26/2023 Octapharma USA, Inc. OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) Food and Beverage In-kind items and services $70.07 General
Category: IMMUNOLOGY
09/26/2023 PFIZER INC. Food and Beverage In-kind items and services $60.08 General
08/24/2023 CSL Behring Hizentra (Biological) Food and Beverage In-kind items and services $66.98 General
Category: Immunology
08/16/2023 Grifols Shared Services North America, Inc. Xembify (Biological) Food and Beverage In-kind items and services $99.86 General
Category: Immunology and Neurology
08/04/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Honoraria Cash or cash equivalent $2,500.00 General
Category: IMMUNOLOGY
08/04/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Travel and Lodging Cash or cash equivalent $163.20 General
Category: IMMUNOLOGY
08/04/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Education Cash or cash equivalent $56.00 General
Category: IMMUNOLOGY
08/04/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Travel and Lodging Cash or cash equivalent $40.00 General
Category: IMMUNOLOGY
08/04/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Travel and Lodging Cash or cash equivalent $40.00 General
Category: IMMUNOLOGY
08/04/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Food and Beverage Cash or cash equivalent $27.00 General
Category: IMMUNOLOGY
08/04/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Food and Beverage Cash or cash equivalent $26.88 General
Category: IMMUNOLOGY
08/04/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Education Cash or cash equivalent $23.58 General
Category: IMMUNOLOGY
08/04/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Food and Beverage Cash or cash equivalent $19.87 General
Category: IMMUNOLOGY
06/13/2023 PFIZER INC. OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG Food and Beverage In-kind items and services $58.49 General
Category: IMMUNOLOGY
05/21/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Education Cash or cash equivalent $84.00 General
Category: IMMUNOLOGY
05/21/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Travel and Lodging Cash or cash equivalent $48.50 General
Category: IMMUNOLOGY
05/21/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Travel and Lodging Cash or cash equivalent $45.00 General
Category: IMMUNOLOGY
05/21/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Education Cash or cash equivalent $26.20 General
Category: IMMUNOLOGY
05/21/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Education Cash or cash equivalent $10.00 General
Category: IMMUNOLOGY
05/21/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Food and Beverage Cash or cash equivalent $4.06 General
Category: IMMUNOLOGY
05/20/2023 Octapharma USA, Inc. CUTAQUIG (Biological) Food and Beverage In-kind items and services $142.54 General
Category: IMMUNOLOGY

Research Studies & Clinical Trials

Study Name Company Amount Records
SCGAM-03 Octapharma USA, Inc. $5,800 2
SCGAM-06 Octapharma USA, Inc. $4,300 3

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 8 345 2,428 $159,593 $73,837
2020 8 319 620 $70,128 $21,068
Total Patients
664
Total Services
3,048
Medicare Billing
$94,905
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J2357 Injection, omalizumab, 5 mg Office 2021 15 1,695 $78,750 $46,693 59.3%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 117 208 $36,400 $13,010 35.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 80 113 $28,250 $10,309 36.5%
95117 Injection of incremental dosages of allergen, 2 or more injections Office 2021 38 175 $5,794 $1,262 21.8%
94010 Measurement and graphic recording of total and timed exhaled air capacity Office 2021 34 37 $2,775 $808.82 29.1%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2021 18 76 $3,800 $766.08 20.2%
95115 Injection of incremental dosages of allergen Office 2021 20 99 $2,574 $626.04 24.3%
95012 Measurement of inhaled nitric oxide gas Office 2021 23 25 $1,250 $362.75 29.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 124 191 $30,880 $9,852 31.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 69 90 $21,500 $6,860 31.9%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 14 14 $4,780 $1,663 34.8%
95117 Injection of incremental dosages of allergen, 2 or more injections Office 2020 37 148 $4,895 $898.24 18.4%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2020 12 73 $3,650 $664.31 18.2%
94010 Measurement and graphic recording of total and timed exhaled air capacity Office 2020 26 29 $2,131 $557.98 26.2%
95012 Measurement of inhaled nitric oxide gas Office 2020 19 23 $940.00 $287.88 30.6%
95115 Injection of incremental dosages of allergen Office 2020 18 52 $1,352 $284.74 21.1%

About Dr. Roger Kobayashi, M.D

Dr. Roger Kobayashi, M.D is a Allergy & Immunology healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093707754.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Kobayashi, M.D has received a total of $90,088 in payments from pharmaceutical and medical device companies, with $1,004 received in 2024. These payments were reported across 296 transactions from 29 companies. The most common payment nature is "Travel and Lodging" ($31,054).

As a Medicare-enrolled provider, Kobayashi has provided services to 664 Medicare beneficiaries, totaling 3,048 services with total Medicare billing of $94,905. Data is available for 2 years (2020–2021), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Allergy & Immunology
  • Location Omaha, NE
  • Active Since 08/18/2005
  • Last Updated 06/30/2011
  • Taxonomy Code 207K00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1093707754

Products in Payments

  • CUTAQUIG (Biological) $28,600
  • OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) $14,928
  • CUTAQUIQ (Biological) $11,893
  • HYQVIA (Biological) $6,673
  • OCTANORM (Biological) $5,800
  • OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $1,723
  • Hizentra (Biological) $1,063
  • CUVITRU (Biological) $858.95
  • PAXLOVID (Drug) $740.00
  • OCTAGAM (Biological) $582.61
  • Xembify (Biological) $436.07
  • ACTIMMUNE (Drug) $349.43
  • NUCALA (Biological) $301.79
  • Xofluza (Drug) $249.75
  • Gamunex-C (Biological) $178.57
  • XOLAIR (Biological) $153.26
  • Zemaira (Biological) $151.78
  • AMZEEQ (Drug) $124.99
  • CINRYZE (Drug) $118.82
  • JOENJA (Drug) $114.33

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Allergy & Immunology Doctors in Omaha